迈瑞医疗跌破200元大关

Group 1 - The core point of the article is that Mindray Medical's stock price has dropped over 3%, falling below the 200 yuan mark, reaching a new low since 2021 [1] Group 2 - The decline in stock price indicates potential challenges for the company in maintaining investor confidence [1] - The stock performance may reflect broader market trends or specific issues within the medical device industry [1] - The significant drop could attract attention from analysts and investors looking for potential recovery opportunities [1]